Clinical Trial Update: A Study to Test the Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Left Ventricular Diastolic Dysfunction [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluating riociguat for pulmonary hypertension associated with left ventricular diastolic dysfunction has been terminated. The trial status …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Left Ventricular Diastolic Dysfunction
• Pulmonary Hypertension

Drugs mentioned

• Riociguat (riociguat)

Snippet

Sponsor: Bayer | Conditions: Hypertension, Pulmonary, Ventricular Dysfunction, Left | Phase 2 | Status: TERMINATED